Detalhe da pesquisa
1.
Outcomes of patients with therapy-related myeloid neoplasms after treatment with poly(ADP-ribose) polymerase proteins inhibitors for solid tumours.
Br J Haematol
; 201(3): e25-e29, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951293
2.
Advances in the management of higher-risk myelodysplastic syndromes: future prospects.
Leuk Lymphoma
; : 1-12, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712556
3.
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm.
Blood Adv
; 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513082
4.
Germline Predisposition to Myelodysplastic Syndromes.
Cancer J
; 29(3): 143-151, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37195770
5.
Low-Dose Dasatinib (50 mg Daily) Frontline Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: 5-Year Follow-Up Results.
Clin Lymphoma Myeloma Leuk
; 23(10): 742-748, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308342
6.
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study.
Lancet Haematol
; 8(3): e194-e204, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33508247
7.
PHF6 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia.
Leuk Res
; 127: 107044, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36801700
8.
Osteoblastic lesions in systemic mastocytosis associated with hematological malignancy. / Lesiones osteoblásticas en una mastocitosis sistémica asociada a neoplasia hematológica.
Med Clin (Barc)
; 156(9): 469-470, 2021 05 07.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-32461026
9.
Lesiones osteoblásticas en una mastocitosis sistémica asociada a neoplasia hematológica / Osteoblastic lesions in systemic mastocytosis associated with hematological malignancy
Med. clín (Ed. impr.)
; 156(9): 469-470, mayo 2021. ilus
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-211368